The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
2022 · The Lancet · 899 citations
https://doi.org/10.1016/s0140-6736(22)01438-6
N
Nicola Silvestris
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
523
Papers
13.4K
Citations
61
h-index
282
i10-index
Nicola Silvestris is an academic researcher from University of Messina. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies. The author has an h-index of 61, co-authored 445 publications.
ORCID: 0000-0001-7814-7318Papers by this author
worksLiquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
2020 · Journal of Experimental & Clinical Cancer Research · 243 citations
https://doi.org/10.1186/s13046-020-01601-2
Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study
2020 · Annals of Translational Medicine · 211 citations
https://doi.org/10.21037/atm.2020.03.55
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib
2016 · Oncotarget · 94 citations
https://doi.org/10.18632/oncotarget.11565
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer
2021 · Biomedicine & Pharmacotherapy · 89 citations
https://doi.org/10.1016/j.biopha.2021.112516
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target
2010 · Cancer Treatment Reviews · 80 citations
https://doi.org/10.1016/s0305-7372(10)70014-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat